Skip to main content
. 2017 Feb 14;13(4):2432–2436. doi: 10.3892/ol.2017.5736

Table II.

Patient and tumor characteristics for meningiomas assessed by immunohistochemistry for activation/phosphorylation of STAT3 and Ki-67 labeling.

Patient no. Age (years)/gender Location Simpson grade Subtype WHO grade Recurrence Follow-up time Ki-67 index (%) Phospho-STAT3 immunoreactivity
1 45/F R frontal I Meningothelial I No 8 yrs 6 mo 3 0
2 74/F L frontal I Meningothelial I No 8 yrs NA 0
3 49/F Post fossa II Fibrous I No 8 yrs 4 mo 5 0
4 53/M Cervical II Psammomatous I No 6 yrs 0 1
5 46/F R temporal I Transitional I No 6 yrs 1 0
6 58/F Convexity II Meningothelial II Yes 7 mo 9 1
7 74/M R frontal I Meningothelial II Yes 8 mo 8 0
8 14/M L hemisphere II Fibrous II Yes 30 mo 14 1
9 72/M R hemisphere II Meningothelial II Yes 1 yr 17 0
10 19/M Sphenoid II Transitional II No 11 yrs 7 1
11 66/F R frontoparietal I Mixed II No 5.5 yrs 14 0
12 50/M R frontal I Meningothelial II Yes 3 yrs 14 0
13 59/M L frontal II Meningothelial II Yes 4 yrs 15 1
14 11/M R frontoparietal II Transitional II No 14 yrs 5 0

STAT3, signal transducer and activator of transcription 3; F, female; M, male; R, right; L, left; WHO, World Health Organization; mo, months; NA, not assessed; yrs, years.